One recent study examined rates of autism spectrum disorder in children in California, while another in Sweden compared birth defects in infants of mothers with type 1 diabetes and infants of mothers without diabetes.
Two recent studies analyzed the renal effects of medications for type 2 diabetes, one finding lower rates of acute kidney injury with sodium-glucose co-transporter-2 inhibitors and the other finding reduced onset of macroalbuminuria with liraglutide.
The effects of adding liraglutide to insulin treatment were assessed by multiple studies published in the past month.
ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.
In the past month, a new meta-analysis compared metformin to other diabetes drugs, and the FDA expanded metformin's indications in patients with reduced kidney function.
Managing diabetes can negatively impact quality of life for people with the disease, so doctors should consider a patient's treatment burden and the “whole person” when setting goals, 2 studies suggest.
The risks and consequences of hypoglycemia were described by several studies published recently.
Renal side effects of diabetes drugs were in the news in the past month, with one industry-funded study finding an association between empagliflozin and slower progression of kidney disease and the FDA strengthening an existing warning on risk of
Three recent studies reanalyzed past data about the effects of intensive glycemic control and published new findings about how and which patients may benefit.
Predicting cardiovascular events in patients with type 2 diabetes was the focus of multiple recent studies.